Here, we demonstrated that the attenuation of ALDH9A1 in ccRCC triggers aberrant abnormal activation of the AKT-mTOR pathway, which is responsible for the tumor progression and lipid accumulation mediated by SREBP1. This evidence concerns the gene ALDH9A1 and nonpapillary renal cell carcinoma.